Sunday, August 21, 2016

WilmerHale Central to BP's Deepwater Horizon Success


The movie Deepwater Horizon will hit theaters September 30th.  It stars Mark Wahlberg and carries the following tag line "When faced with our darkest hour hope is not a tactic."  That's why BP hired DC powerhouse law firm WilmerHale after the company's 2010 explosion that killed scores of workers.  WilmerHale's Jamie Gorelick led the charge.

President Obama charged Interior Department chief Ken Salazar to conduct a through review of the incident.  Salazar bailed on that charge, deferring to a mix of other study commissions.  Salazar left public service in June 2013 to join WilmerHale.


Ken Salazar has a new job, assembling the White House team for Presidential hopeful Hillary Clinton.  That will be the team that responds to the next disaster.  Ken should have many people to consider if he's at former President Bill Clinton's birthday bash on Martha's Vineyard.

Oddly, the people of Louisiana are the perpetually ignored.  First, Bush strummed while Hurricane Katrina turned New Orleans into a cesspool.  The Obama team was somehow slower than Bush and FEMA poser Michael Brown.  Now flooded Louisianan's have to wait for Bill's birthday soiree to finish so Obama can commiserate with them.  

Update 7-14-23:  WilmerHale is defending JP Morgan for supplying money to child sex trafficker Jeffrey Epstein. 

Update 11-12-23:  WilmerHale's settlement for JP Morgan for enabling Jeffrey Epstein's child sex trafficking prevents state Attorney Generals from bringing action against parties to the settlement.

Monday, August 15, 2016

Axalta: Carlyle's 2nd Biggest Cash In Ever

Bloomberg reported:

When Carlyle Group LP orchestrated a $4.9 billion buyout of DuPont Co.’s auto-paint business in 2013, competitors said the private equity firm overpaid. Three years later, Carlyle has reaped its second-biggest profit ever on the deal.

The asset manager sold on Tuesday its remaining stake in Axalta Coating Systems Ltd., previously known as DuPont Performance Coatings. The $1.35 billion that Washington-based Carlyle plowed into the deal grew to $5.8 billion, according to regulatory filings, through a series of stock sales starting last year.
Axalta CEO Charlie Shaver refocused the company’s auto-refinishing unit to win business from growing multi-shop operators, rather than individual car shops.
Carlyle happened to own a growing multi-shop operator, Service King.   When Carlyle purchased Service King it operated 47 auto body repair centers.  In 2014 when it did a deal with Blackstone Service King had 177 auto body shops.  Carlyle steered all of Service King's business to Axalta during their ownership of both companies.  A OneCarlyle case study stated:

  • Entered into an enterprise-wide supply partnership with Axalta Coating Systems (a Carlyle Partners V portfolio company), a global provider of liquid and powder coatings in the automotive industry
The Carlyle Group purchased a UK based auto repair chain, Nationwide Accident Repair Services (NARS), in early 2015. The NARS network now stands at 124 sites following its most recent acquisition.

Carlyle may be skilled in reading which industries are ready to turn around, but I believe they steer business between affiliates to accelerate changes.

Carlyle got in and out of Landmark Aviation several times.  The PEU is in a position to steer affiliate private jet needs to Landmark during periods of Carlyle ownership and guide it elsewhere later should it suit.  Carlyle's most recent Landmark sale garnered over $2 billion.

Bloomberg missed Carlyle's first roundtrip on Landmark Aviation when it sold the company to Dubai Aerospace for $1.8 billion.  Carlyle had the connections to keep the deal on the down low between the Dubai Ports brouhaha and the NASDAQ-Bourse fiasco.

On the second Landmark sale Carlyle used someone with connections.  Ironically it's an attorney who likes to race cars.  I wonder if he got any free Axalta paint from the deal.

Update 8-16-16:  Carlyle announced a deal to buy mobile security company, NetMotion, which targets large enterprise customers.  Carlyle owns more than a handful of those.

Friday, August 12, 2016

PPACA Shortfall in Number of People Covered


Medicare's Chief Actuary predicted an additional 27.7 million people would have health insurance coverage in 2016 under PPACA, now widely referred to as Obamacare.  As of March 31 the number with coverage stood at 11.1 million, 16.6 million people less than projected.  That's 60% short of its target in PPACA's third year of exchange operation.

Advertising, or the lack thereof, is not the cause of people passing on coverage.  The United States' healthcare system is byzantine in its complexity and bizarrely expensive.  PPACA does nothing to address these faults.

It does shift the burden of coverage from employers to a tapped out Uncle Sam and the individual.  Notice the projected decline in workplace coverage for 1.5 million people.  It will be interesting to see the Census Bureau's projections on employer coverage in September.

Update 8-15-16:  Health exchange insurance policies are going up 24% for 2017.   Given its shortfall in coverage and failure to reign in healthcare costs PPACA is terminal. 

Update 9-25-19:  Employers shifted costs to employees via higher deductibles and increased co-pays.   PPACA has not helped make healthcare more affordable.  It has made a lot of money for the PEU boys. 

Update 4-3-22:   The average health insurance premium more than tripled for a family plan since PPACA passed in 2010.  Cost curve bent but in the wrong direction.  Concave went convex.  

Saturday, August 6, 2016

PPACA Creators Truly Shameless


Two founders of the Patient Protection and Affordable Care Act (PPACA), Nancy Ann Deparle and Neera Tanden, served on healthcare panel at the Democratic National Convention in Philadelphia.  Between them sat a major PPACA influencer ex-Senator Tom Daschle, now a non-lobbying lobbyist with Alston and Bird and private equity underwriter (PEU).

Nancy Ann reminisced about how everyone came together to "bend the cost curve."  She did not address their abject failure the last few years as health care costs exploded.  The panel talked about the current concern of affordability but acted like cost drivers had nothing to do with PPACA.  One of the six major areas in the bill included:

Provisions aimed in part at changing the trend in health spending growth
Here's the government's prediction for overall healthcare spending:

"... we estimate that overall national health expenditures under the health reform act would increase by a total of $311 billion (0.9 percent) during calendar years 2010-2019."
Failure to act on drivers of hypersonic healthcare cost increases means greed remains in charge.  Incentives and competition for a bigger piece of the pie clearly have not worked.  The groups that "gave so the public could save" included health insurers, big pharma, hospitals and healthcare providers.

Hospital giant HCA's stock went from $21 a share in 2012 to $75 on Friday.  KKR and Bain Capital's ownership of HCA from 2006 to 2011 added $15 billion in healthcare costs due to higher interest expense, the imposition of annual management fees and PEU owners borrowing to pay themselves over $4 billion in dividends.

Aetna went from $36 per share in 2012 to nearly $120 a share on Friday.  Oddly, Tom Daschle's former law firm added an Aetna attorney earlier this year to bolster their health regulatory practice.

Tom Daschle joined Baker Donelson in 2014, forming a public policy consulting arm called The Daschle Group.  Public Policy groups are as hard to keep up with as private equity underwriters.


The Fiscal Times recently featured Tom Daschle in a story on Accumen, a lab consulting firm helping hospitals cut lab costs,  Accumen is an affiliate of Accretive LLC, a private equity underwriter.  The story revealed Daschle to be a public policy advisor and lobbyist for Accumen. 

Lobbyists and PEUs are part of the big money cycle that makes our country not work for the average person.  PPACA is clearly part of that greed cycle.  The DNC panel and Daschle story reveal how PPACA's creators and profiteers are truly shameless.  In many cases they are one and the same.

Update 3-15-18:   Skyhigh healthcare costs differentiate the U.S. from the rest of the globe.  PPACA's cost curve bent in the wrong direction, acceleration.

Update 9-4-19:   Tanden is deep in the Democratic Presidential nomination, taking the side of Blue Corporacrats.

Update 9-25-19:  Employers shifted costs to employees via higher deductibles and increased co-pays.   PPACA has not helped make healthcare more affordable.  It has made a lot of money for the PEU boys. 

Update 2-19-21:  Nancy Ann Deparle had a banner payday after Consonance Capital sold Enclara Healthcare to Humana in 2020.  Enclara is "one of the nation's largest hospice and benefit management providers."  Yet, Humana intends to spin off Kindred Hospice as it prefers a partnership model for end of life care.

Friday, August 5, 2016

PPACA Doc is PEU with Venrock


WSJ ran an opinion piece from Dr. Kocher who helped create PPACA, widely known as Obamacare.  He stated:

In my White House days, we believed it would take three to five years for physicians to use electronic health records effectively. We were wrong about that too. At every opportunity, organized medicine has asked to delay and lower thresholds for tracking and reporting basic quality measures; yet they have no reason to delay.

In the ACOs run by Aledade, which advises small medical practices (I sit on its board), we have found that independent primary-care doctors are able to change their care models in weeks and rapidly learn how to use data to drive savings and quality. 
A more accurate disclosure would've said my employer has significant investments in Aledade and my compensation could be increased by my driving business to the company by this Wall Street Journal piece.

Venrock first invested in Aledade in 2014.  The press release stated Venrock was "originally established as the venture capital arm of the Rockefeller family in 1969."  Venrock was the Series A funder for Aledade according to Crunchbase.  The first investor has the greatest chance to land a larger equity stake.

Likely as a result of Venrock's investment Aledade got $30 million in Series B funding from ARCH Venture Partners in 2015.  Venrock added to their initial Aledade stake in the Series B deal.

Venrock has a $450 million fund specializing in the intersection of health care and technology. 

Tuesday, August 2, 2016

NYT Pushes PEU Dependence on Public


NYT's Bottom Line Nation published an odd series of slides praising the impact of private equity underwriters (PEU).  Readers are free to scroll through their slides in a search for actual substance.  I offer a historical perspective from a former major financial news reporter.

There are very few people out there who will talk and write honestly about private equity. I know from personal experience that the financial press is so eager to break news on "deals" that reporters (who are increasingly compensated on the number of "market moving stories" they write) can't afford to be critical of Carlyle, KKR and Blackstone, and risk losing access to people at those firms.

NYT's Slide 4 states "Private equity firms are essentially savvy bargain hunters. They make money by buying up businesses they consider to be underperforming, looking to maximize profits and eventually sell them off."

The "daily life" products shown in NYT's slides are made and used by people.
I have seen so many people -- particularly those in their 50s - 70s -- taken apart by what has happened in their industry as greed has hollowed out the economy. These are people took pride in their jobs and held themselves to this invisible standard that we all just took for granted, but is being wiped out.
Slide 5 in the private equity promo offered "These investors have lots of money at their disposal, mainly from rich individuals and pension funds. They also face fewer regulations than banks. Since the 2008 financial crisis, they’ve expanded their horizons and begun shopping for bargains in new places."

I can remember Bloomberg's private equity reporter - who you featured in a recent blog photo - going on TV to talk about the HCA dividend and calling it a "liquidity event." The reporters are trained by the PE firms' PR people to use language that they find acceptable. Wouldn't want to say they're "cashing out." I've never seen anything like it before. 
KKR added billions in new healthcare costs with its ownership of hospital giant HCA but that should not be a surprise given President Obama's health reformer Nancy Ann Deparle came from private equity.  To the private equity swamp she returned after her years of "public service."  This points to how private equity utilizes government to pave the way for their next round of profits.

The Carlyle Group scares me more than anything I've ever seen on Wall Street. It seems to exist to corrupt politicians and it's hard to know who they even represent.
I watched a video interview of (David) Rubenstein and his arrogance is really beyond tolerance. He was going on about the debt ceiling problem and how there would need to be cuts in services and higher taxes. When the reporter asked him about tax on carried interest he turned really disdainful and said that this "only" amounted to $22 billion over some number of years and this was not serious money. Boy, nothing like everybody doing their small part to save the country from oblivion!
Rubenstein saved private equity's preferred taxation, a feat recently recognized by Harvard University's investment arm.

NYT's piece on private equity ended in a puff of smoke, where PEU owned emergency responders have slower response times.  I'm sure the public feels better knowing profits outweigh their personal safety.


A different Bottom Line Nation story stated:

The amount the private equity industry spent on lobbying in 2015 was more than triple what it had spent a decade earlier, according to the Center for Responsive Politics. At the peak of the financial crisis, the figure was even higher. Political donations have increased nearly sixfold.
Remember:  Politicians Red and Blue love PEU!  If private equity is so integral to daily life NYT could be paving the way for the next bailout.

Note:  PEUReport houses ten years of stories showing the impact of private equity.  Feel free to search the site for issues important to you.  There might be actual information on private equity's impact, current or historical.

Carlyle Group PEUs Face Clawback for Riverstone Funds

WSJ reported:

Top executives at Riverstone Holdings LLC, one of the world’s largest energy investment firms, face the prospect of returning more than $300 million of profits they made from investments before the oil bust erased those gains, according to securities filings and people familiar with the matter.

The money is related to an incentive formula employed at private-equity firms in which executives earn a cut of profits above a certain threshold for each fund.

In Riverstone’s case, profits in some of its funds shriveled after U.S. oil prices plunged to below $27 a barrel earlier this year from more than $100 in mid-2014. That decline reduced the value of some companies owned by Riverstone, eliminating paper gains and could require some executives to return profits in a so-called clawback if the investments don’t regain value before the funds that hold them are liquidated.

David Leuschen and Pierre Lapeyre Jr., who founded Riverstone and remain its majority owners, are the primary recipients of its portion of deal profits, known as carried interest. Through a spokesman, Messrs. Leuschen and Lapeyre declined to comment.
Carlyle Group executives join Riverstone's founders in having skin in the game.

The firm initially teamed up with Carlyle Group LP, which helped the upstart raise money and handle back-office functions in exchange for a stake in Riverstone’s funds. That partnership lasted for several funds before Riverstone struck out on its own for a $7.7-billion fund it raised in 2013.

Carlyle said in a securities filing that as of June 30 it had set aside $76 million in gains it owes back to three funds it manages alongside Riverstone based on the investment pools’ present value.

Each of the three Riverstone funds that Carlyle says are subject to the clawback remained profitable for investors as of June 30 but have fallen below the minimum level of profitability that entitles the firms to a cut of the gains. They are the only of Carlyle’s 34 funds in clawback, company filings show.

When Carlyle reported second-quarter results last week, analysts asked executives why another of its funds, which had gained enough for the firm and its shareholders to start taking their cut, hadn’t started paying out. Carlyle’s executives said they wanted to ensure the profits were permanent lest they wind up having to return money.

“Investors aren’t happy with clawback,” said Carlyle co-CEO David Rubenstein, “but the professionals in our firm are even less happy when we have to claw back.”
So much for pay for performance.  Carlyle's PEU professionals might ask Uncle Sam to carry them until times get better, like the U.S. Treasury did for Carlyle's Boston Private via TARP.